Triall’s mission is to enable a future of smarter, safer, and more-efficient clinical trials by leveraging the latest emerging technologies.
We offer a modular and fully-integrated suite of clinical trial software (eClinical) solutions for all core study functions, including EDC, ePRO/eCOA, eSource, eConsent, eTMF, CTMS, RTSM, Wearable integration, and more.
Triall’s end-to-end platform is designed to support any therapeutic area, any trial type (decentralised, hybrid, site-based), and any trial phase (I-IV).
Moreover, we apply blockchain to generate verifiable proof of the integrity of clinical trial data and leverage Self-Sovereign Identity (SSI) technologies to provide patients and clinicians with more ownership and control over their data, documents, and processes.
Check out our website triall.io or reach out to our team at contact@triall.io to learn more about our platform and technologies.
Location: Netherlands, Utrecht, Maarssen
Employees: 11-50
Total raised: $2.4M
Founded date: 2018
Investors 3
| Date | Name | Website |
| - | BlackDrago... | blackdrago... |
| - | Zokyo | zokyo.io |
| - | CSP DAO | cspdao.net... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.07.2021 | Seed | $2.4M | - |